The Food and Drug Administration FDA has granted marketing approval for tacrolimus capsules and tacrolimus injection Prograf/Fujisawa, for prophylaxis of. Sep 10, 2003. Prograf tacrolimus Injection Company Fujisawa Application No. 050708. Approval Date 04/08/1994. Persons with disabilities having. Mar 11, 2014. Read more at.
Drug Approval Package Prograf tacrolimus NDA # 050708 - FDA
PROTOPIC tacrolimus Ointment contains tacrolimus, a macrolide. This Medication Guide has been approved by the U. S. Food and Drug Administration. Protopic tacrolimus Ointment Company Fujisawa Application No. 050777. Approval Date 12/08/2000. Approval Letter PDF. Final Printed Labeling PDF. FDA approval history for Astagraf XL tacrolimus used to treat Organ Transplant, Rejection Prophylaxis. Supplied by Astellas Pharma US, Inc.
TACROLIMUS New Drug Approvals
See full prescribing information for. PROGRAF. PROGRAF® tacrolimus capsules. PROGRAF® tacrolimus injection, for intravenous use. Initial U. S. Approval. Jul 23, 2015. Tacrolimus marketed as Protopic Ointment Information. The Food and Drug Administration FDA has approved updated labeling on.
Tacrolimus anda #090596 - [email protected] FDA Approved Drug.
Drug Name, Active Ingredients, Strength, Dosage Form/Route, Marketing Status, TE Code, RLD, RS. TACROLIMUS, TACROLIMUS, EQ 0.5MG BASE. Prograf is available for oral administration as capsules tacrolimus capsules. Prograf is also available as a sterile solution tacrolimus injection containing the.